Privacy Policy
Effective date: 1 January 2026
Clinivion Ltd. ("Clinivion", "we", "us") operates clinivion.com and nessa.clinivion.com. This policy explains how we collect, use, and protect information about you.
1. Information We Collect
We collect information you provide directly, including:
- Contact information (name, email address, company) when you request a demo or contact us
- Usage data from our Nessa platform, including audit log metadata and session information
- Technical data such as IP address, browser type, and pages visited
2. How We Use Your Information
We use collected information to:
- Provide, maintain, and improve the Nessa data integrity platform
- Respond to enquiries and fulfil demo requests
- Send service updates and compliance-relevant communications
- Ensure the security and integrity of our systems
3. Data Integrity & Pharmaceutical Compliance
Our platform is designed to support FDA 21 CFR Part 11 and ALCOA+ compliance requirements. Clinical data processed through Nessa is handled with cryptographic audit trails to ensure attributability, legibility, contemporaneity, originality, and accuracy.
We do not use clinical trial data for purposes other than providing our services. All data is processed in accordance with GxP validation principles.
4. Data Sharing
We do not sell your personal data. We may share information with:
- Service providers operating under confidentiality agreements
- Regulatory authorities where required by law
- Auditors in connection with GxP or SOC 2 compliance reviews
5. Data Retention
We retain personal data for as long as necessary to provide our services or comply with legal obligations. Audit trail data is retained in accordance with applicable regulatory requirements (typically a minimum of 7 years for GxP records).
6. Your Rights
You have the right to access, correct, or delete your personal data. To exercise these rights, contact us at hello@clinivion.com.
7. Security
We implement industry-standard security measures including encryption at rest and in transit, role-based access controls, and continuous monitoring. See our Security Policy for details.
8. Contact
Clinivion Ltd.
hello@clinivion.com